Informed consent: the FDA's perspective.
D000163:Acquired Immunodeficiency Syndrome; D002648:Child; D030881:Disclosure; D015507:Drugs, Investigational; D004864:Equipment and Supplies; D017041:Ethics Committees; D028744:Ethics Committees, Research; D035082:Federal Government; D005260:Female; D005333:Fetus; D005380:Financing, Government; D006076:Government; D033161:Government Regulation; D017408:Guidelines as Topic; D006805:Human Experimentation; D006801:Humans; D007258:Informed Consent; D033282:Parental Consent; D004364:Pharmaceutical Preparations; D011247:Pregnancy; D037841:Pregnant People; D011640:Public Policy; D012107:Research Design; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D020458:Third-Party Consent; D014481:United States; D014483:United States Dept. of Health and Human Services; D014486:United States Food and Drug Administration; D014930:Women; D016387:Women's Health; D015215:Zidovudine
Biomedical and Behavioral Research; Legal Approach